Overview of secondary liver cancer care pathways, key treatment steps, and the situations where dendritic cell treatment may be discussed as a selected option.

A phase 2 trial showed that combining targeted radiotherapy with PD-1 blockade and a bevacizumab biosimilar can elicit responses in advanced liver cancer.

A diagnosis of serious liver disease can feel like a slow countdown. Scar tissue builds quietly, the liver stiffens, and the ...

Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and one of the leading causes of cancer-related deaths worldwide. Early detection and accurate diagnosis are crucial for effective ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) can cause more serious liver conditions, such as liver failure. A new study, led by Lund University in Sweden, presents new data that ...

Symptoms of liver cancer don’t usually appear early on. You can’t see your liver from the outside, so it’s not like skin cancer, where there’s a lesion on your skin. A lot of cancers cause pain or a ...

What Is a Liver Ultrasound? A liver ultrasound is a type of abdominal ultrasound, an imaging test that uses high-frequency sound waves to create pictures of the organs and structures in your abdomen, ...

Phase Ib study of mapatumumab in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC) and chronic viral hepatitis. Exposure-response (E-R) analysis to facilitate phase ...